UNICYCIVE THERAPEUTICS, INC. (UNCY) Debt Components
- 2023-12-31: Convertible Notes Payable, CurrentUSD (m); Debt Instrument, Face AmountUSD $2.20M; Debt Instrument, Periodic PaymentUSD (m); Debt Instrument, Increase, Accrued InterestUSD (m).
- 2023-09-30: Convertible Notes Payable, CurrentUSD (m); Debt Instrument, Face AmountUSD $1.80M; Debt Instrument, Periodic PaymentUSD (m); Debt Instrument, Increase, Accrued InterestUSD (m).
- 2023-06-30: Convertible Notes Payable, CurrentUSD (m); Debt Instrument, Face AmountUSD $2.20M; Debt Instrument, Periodic PaymentUSD (m); Debt Instrument, Increase, Accrued InterestUSD (m).
- 2023-03-31: Convertible Notes Payable, CurrentUSD (m); Debt Instrument, Face AmountUSD $2.00M; Debt Instrument, Periodic PaymentUSD (m); Debt Instrument, Increase, Accrued InterestUSD (m).
UNICYCIVE THERAPEUTICS, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Convertible Notes Payable, Current USD | Debt Instrument, Face Amount USD | Debt Instrument, Periodic Payment USD | Debt Instrument, Increase, Accrued Interest USD |
|---|---|---|---|---|
| 2023-12-31 | (m) | $2.20M | (m) | (m) |
| 2023-09-30 | (m) | $1.80M | (m) | (m) |
| 2023-06-30 | (m) | $2.20M | (m) | (m) |
| 2023-03-31 | (m) | $2.00M | (m) | (m) |
| 2022-08-31 | (m) | (m) | $1.00M | (m) |
| 2021-07-15 | (m) | (m) | (m) | $191.00K |
| 2021-07-13 | (m) | (m) | (m) | $191.00K |
| 2021-06-30 | $3.20M | (m) | (m) | (m) |
| 2020-12-31 | $1.53M | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |